IGM Biosciences, Inc. short interest in 2021
In 2021, IGM Biosciences, Inc.'s disclosed short interest ran from 9.36% of shares outstanding on 30 Apr 2021 to 12.73% on 31 Dec 2021, a change of +3.37 percentage points. The year's high was 12.73% on 31 Dec 2021 and its low 8.99% on 28 May 2021, averaging 10.12% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 37.64 days on 15 Oct 2021. Full history: IGM Biosciences, Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025
2021 in figures
- Start of year
- 9.36% (30 Apr 2021)
- End of year
- 12.73% (31 Dec 2021)
- Change
- +3.37 pp
- High
- 12.73% (31 Dec 2021)
- Low
- 8.99% (28 May 2021)
- Average
- 10.12%
- Highest days to cover
- 37.64 (15 Oct 2021)
- SEC filings marked
- 9
Every report in 2021
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 30 Apr 2021 | 9.36% | 20.07 | results (8-K), 10-K filed, results (8-K) |
| 14 May 2021 | 9.31% | 16.14 | 10-Q filed, results (8-K) |
| 28 May 2021 | 8.99% | 29.12 | |
| 15 Jun 2021 | 9.56% | 15.63 | |
| 30 Jun 2021 | 9.21% | 20.20 | |
| 15 Jul 2021 | 9.13% | 30.85 | |
| 30 Jul 2021 | 9.21% | 18.21 | |
| 13 Aug 2021 | 10.38% | 20.17 | 10-Q filed, results (8-K) |
| 31 Aug 2021 | 10.36% | 28.95 | |
| 15 Sep 2021 | 9.97% | 30.06 | |
| 30 Sep 2021 | 9.87% | 21.62 | |
| 15 Oct 2021 | 10.17% | 37.64 | |
| 29 Oct 2021 | 10.32% | 19.22 | |
| 15 Nov 2021 | 11.11% | 11.53 | 10-Q filed, results (8-K) |
| 30 Nov 2021 | 11.23% | 18.42 | |
| 15 Dec 2021 | 11.14% | 7.89 | |
| 31 Dec 2021 | 12.73% | 13.71 |
See also: IGM Biosciences, Inc.'s full history · most shorted US stocks of 2021 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.